We constructed and screened a gene bank of phase i chroinosomal DNA of Bordetella pertussis in Escherichia coli. A single immunopositive clone was recovered, and the hybrid plasmid obtained, designated pFSH200, had a molecular size of 46.6 kilobases. Smaller derivatives were generated by partial digestion of plasmid pFSH200 and were further characterized. One such derivative, plasmid pFSH201, contained a 4.5-kilobase chromosomal DNA fragment of B. pertussis which coded for the synthesis of the two outer membrane proteins of 33 and 30 kilodaltons specific to B. pertussis.
Bordetella pertussis, the causative agent of whooping cough, is a fastidious microorganism which displays several determinants of pathogenicity such as lymphocytosis promoting factor (14) , protective antigens (18) , fimbrial hemagglutinin (19) , dermonecrotic toxin (2) , and extracellular adenylate cyclase (5) . Presently, there is a great deal of interest in these cellular components, some of which are major outer membrane proteins (17) , as potential immunogenic proteins to be incorporated into a subcellular vaccine. These antigens, which are involved in the protection of mice against intracerebral challenge with B. pertussis and probably in the protection of children against whooping cough, are biochemically characterized, although genetic analysis of their immunological activities has not received much attention. B. pertussis strains have shown phase variation (fron phase I to phase IV) after in vitro passage (9) and a phenotypic change, similar to the osmoregulation of the expression of the porins of Escherichia coli (16) called antigenic modulation (from X mode to C mode), when the organism is grown in medium containing a high concentration of Mg2+ (7, 23) . Phase IV strains and C-mode cells are characterized by a loss or attenuation of several antigenic determinants and certain outer membrane proteins (3, 15, 17) , which are mainly the proteins of 90, 86, 81, 33, and 30 kilodaltons (Kd) (17) and the five subunits of the pertussis toxin (IAP, LPF), which are low-molecular-weight proteins (21 (20) , and chromosomal DNA was-extractedby the method of Marmur (10) (11) . The autoradiogram of the experiment revealed that a single clone was immunopositive. This positive clone was picked up from the master plate, purified twice on the same medium, and tested again with mouse antiserum before further analysis. Plasmid pFSH200 was extracted from the clone, and agarose gel analysis of BamHI restriction fragments (Fig. 1A) enabled us to determine that plasmid pFSH200 consisted of cosmid pHC79 (6.43 kb) and five chromosomal fragments of 15, 12.5, 4.7, 4.3, and 3.7 kb, for a total length of 46.6 kb.
The replicon in plasmid pHC79 is derived from that of plasmid ColEl, which is under relaxed control (ca. 50 copies of plasmid per cell). The large plasmid pFSH200, however, isolated from the positive clone could have a copy number as low as five copies per cell and could be lost by segregation during growth in the absence of antibiotic selection (6) . Thus, to stabilize the plasmid DNA by increasing the copy number of plasmid pFSH200 and to localize more precisely the structural gene(s) coding for the synthesis of B. pertussis-specific proteins, we attempted to obtain the smallest plasmid derived from plasmid pFSH200 that was still capable of producing these immunoreactive proteins. Digestion of plasmid pFSH200 with restriction endonuclease Sall yielded more than 20 fragments (cosmid pHC79 is cleaved only once by Sall). Thus, plasmid pFSH200 was partially digested with Sall endonuclease and ligated with T4 DNA ligase; smaller de-ivatives were introduced by transformation into E. coli DH1 by the method of Hanahan (4 was needed for the replication and maintenance of all smaller plasmids. The presence of the additional fragments of 1.4 and 1.1 kb present in all positive clones derived from pFSH200 suggest that these three chromosomal DNA fragments are necessary for the synthesis of the immunoreactive proteins of B. pertlussis. In fact, the clone harboring plasmid pFSH202, which lacked the 1.4-kb Sall fragment, was negative and did not produce any proteins specific to B. pertussis (Fig. 1, lane 12) . The restriction map of plasmid pFSH201 is shown in Fig. 2 . Endonuclease restriction analysis of plasmid pFSH201 revealed that in the process of partial digestion of plasmid pFSH200 with Sall, the small fragment of plasmid pHC79 spanning from the unique Sall site and including the nearest BamHI site was deleted (275 base pairs). Thus, plasmid pFSH201 contains a 4.5-kb fragment of chromosomal DNA of B. pertussis that codes for the synthesis of proteins specific to B. pertiussis.
The immunoreactive proteins expressed by plasmids pFSH200 and smaller derivatives were analyzed by Western blotting of sodium dodecyl sulfate-solubilized total proteins of bacteria harboring these plasmids. The autoradiogram revealed that two proteins encoded by these plasmids reacted with the mouse immune serum against B. pertussis and that these proteins had an estimated size of 33 and 30 Kd (data not shown). No protein or truncated immunoreactive protein was synthesized by the clone harboring plasmid pFSH202, which lacked the 1.4-kb Sall fragment found in all positive smaller derivatives of plasmid pFSH200. The 1.4-kb Sall fragment may contain part of the structural genes or transcriptional signals necessary for protein synthesis. The proteins coded by plasmid pFSH201 were localized by analyzing the soluble and envelope fractions of cells harboring this plasmid by the method of Morona and Reeves (13) . In Fig. 3, lane 2 , it is shown that the two immunoreactive proteins of 33 and 30 Kd are processed into the outer membrane of E. coli DH1 as they are in B. pertussis. This is the first report that deals with the molecular cloning and expression in E. coli of two major outer membrane proteins of B. pertiussis. In plasmid pFSH200, we Furthermore, isolation of plasmid pFSH201 opens a new field of research in the genetically engineered production of these proteins as potential protective antigens. We are currently undertaking studies to determine precisely the organization of these genes with regard to their promoter sequence to increase the synthesis of these proteins by modifying the transcription of their structural genes. However, as shown in Fig. 3, lane 4 , at least eight proteins reacted with the mouse immune serum against Formalin-fixed B. pertlussis cells. The molecular weight of these proteins corresponds to those of the outer membrane proteins extracted from phase I B.
pertiussis (17) . Our failure to recover other immunopositive clones that synthesize these proteins, during the screening of the gene bank of B. pertiussis in E. (coli, could be explained if we consider the model of the regulation of expression of outer membrane proteins of B. petiussis proposed recently by Weiss and Falkow (24) . According to this model, a transacting gene product is required as a positive effector for the expression of the structural genes that code for the synthesis of the outer membrane proteins of B. pertiissi.s. Studies are in progress to identify in plasmid pFSH200 and in smaller derivatives whether such a gene or gene product is present and necessary for the expression of the outer membrane proteins of B. pertissis in E. (ol/i. 
